Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults.

Tau is associated with hypometabolism in patients with Alzheimer's disease. In normal aging, the association between tau and glucose metabolism is not fully characterized. We used [18F] AV-1451, [18F] Fluorodeoxyglucose, and [11C] Pittsburgh Compound-B (PiB) PET to measure associations between tau and glucose metabolism in cognitively normal older adults (N = 49). Participants were divided into amyloid-negative (PiB-, n = 28) and amyloid-positive (PiB+, n = 21) groups to determine effects of amyloid-β. We assessed both local and across-brain regional tau-glucose metabolism associations separately in PiB-/PiB+ groups using correlation matrices and sparse canonical correlations. Relationships between tau and glucose metabolism differed by amyloid status, and were primarily spatially distinct. In PiB- subjects, tau was associated with broad regions of increased glucose metabolism. In PiB+ subjects, medial temporal lobe tau was associated with widespread hypometabolism, while tau outside of the medial temporal lobe was associated with decreased and increased glucose metabolism. We further found that regions with earlier tau spread were associated with stronger negative correlations with glucose metabolism. Our findings indicate that in normal aging, low levels of tau are associated with a phase of increased metabolism, while high levels of tau in the presence of amyloid-β are associated with hypometabolism at downstream sites.

[1]  Jane Mummery,et al.  Regional , 2019, M/C Journal.

[2]  Jorge Sepulcre,et al.  Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.

[3]  Theresa M. Harrison,et al.  Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging , 2017, The Journal of Neuroscience.

[4]  W. Jagust,et al.  Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.

[5]  Reisa A. Sperling,et al.  The association between tau PET and retrospective cortical thinning in clinically normal elderly , 2017, NeuroImage.

[6]  William J. Jagust,et al.  Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease , 2017, NeuroImage.

[7]  Keith A. Johnson,et al.  Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals , 2017, The Journal of Neuroscience.

[8]  W. Jagust,et al.  Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging , 2017, The Journal of Neuroscience.

[9]  Jorge Sepulcre,et al.  Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline , 2017, Annals of neurology.

[10]  Gereon R. Fink,et al.  Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.

[11]  Hanna Cho,et al.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.

[12]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[13]  Yi Su,et al.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease , 2016, Science Translational Medicine.

[14]  Daniel R. Schonhaut,et al.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.

[15]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[16]  Sylvia Richardson,et al.  A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies , 2016, Science Translational Medicine.

[17]  N. Albert,et al.  Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study , 2016, The Journal of Nuclear Medicine.

[18]  Anirvan Ghosh,et al.  Specification of synaptic connectivity by cell surface interactions , 2015, Nature Reviews Neuroscience.

[19]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[20]  W. Jagust,et al.  Regional brain hypometabolism is unrelated to regional amyloid plaque burden. , 2015, Brain : a journal of neurology.

[21]  Keith A. Johnson,et al.  Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.

[22]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[23]  Daniel R. Schonhaut,et al.  Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy , 2015, Annals of neurology.

[24]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[25]  D. Y. Lee,et al.  Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[26]  Cindee M. Madison,et al.  Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? , 2014, Cerebral cortex.

[27]  C. Jack,et al.  Association of hypometabolism and amyloid levels in aging, normal subjects , 2014, Neurology.

[28]  Cindee M. Madison,et al.  Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly , 2014, Human brain mapping.

[29]  H. Kolb,et al.  [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.

[30]  Zhenghui Hu,et al.  The Relationship between Cerebral Glucose Metabolism and Age: Report of a Large Brain PET Data Set , 2012, PloS one.

[31]  W. Jagust,et al.  Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.

[32]  G. Chételat,et al.  Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.

[33]  D. Attwell,et al.  Synaptic Energy Use and Supply , 2012, Neuron.

[34]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[35]  B. Miller,et al.  Cognition, glucose metabolism and amyloid burden in Alzheimer's disease , 2012, Neurobiology of Aging.

[36]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  Michael D. Greicius,et al.  Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. , 2011, Cerebral cortex.

[38]  M. Weiner,et al.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.

[39]  R. Tibshirani,et al.  A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. , 2009, Biostatistics.

[40]  M. Witter,et al.  What Does the Anatomical Organization of the Entorhinal Cortex Tell Us? , 2008, Neural plasticity.

[41]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  J. Baron,et al.  Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[43]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  Akihiko Takashima,et al.  Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.

[45]  Jean-Claude Baron,et al.  Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons , 2003, NeuroImage.

[46]  W. Härdle,et al.  Applied Multivariate Statistical Analysis , 2003 .

[47]  W. Klunk,et al.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.

[48]  J. Baron,et al.  Efficient principal component analysis for multivariate 3D voxel‐based mapping of brain functional imaging data sets as applied to FDG‐PET and normal aging , 2003, Human brain mapping.

[49]  J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.

[50]  J. Morrison,et al.  Determinants of neuronal vulnerability in neurodegenerative diseases , 1998, Annals of neurology.

[51]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[53]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[54]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[55]  D. Pandya,et al.  Some observations on the course and composition of the cingulum bundle in the rhesus monkey , 1984, The Journal of comparative neurology.

[56]  H. Hotelling Relations Between Two Sets of Variates , 1936 .

[57]  D. Y. Lee,et al.  Association of Cerebral Amyloid-&bgr; Aggregation With Cognitive Functioning in Persons Without Dementia , 2018, JAMA psychiatry.

[58]  A. A. Farooqui,et al.  Slow excitotoxicity in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[59]  Udo Rüb,et al.  Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. , 2006, Journal of Alzheimer's disease : JAD.

[60]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.